Fluorescence in Situ Hybridization Study of HER-2/neu Oncogene Amplification in Prostate Cancer

Author： Mark H.F.L.   Feldman D.   Das S.   Kye H.   Mark S.   Sun C.-L.   Samy M.  

Publisher： Elsevier

ISSN： 0014-4800

Source： Experimental and Molecular Pathology, Vol.66, Iss.2, 1999-06, pp. : 170-178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fluorescence in Situ Hybridization Analysis of HER-2/neu, c-myc, and p53 in Endometrial Cancer

By Williams J.A.   Wang Z.-R.   Parrish R.S.   Hazlett L.J.   Smith S.T.   Young S.R.  

Experimental and Molecular Pathology, Vol. 67, Iss. 3, 1999-12 ,pp. : 135-143

Elsevier

Access to resources Recommend Favorite

Fluorescent in Situ Hybridization Study of c-myc Oncogene Copy Number in Prostate Cancer

By Mark H.F.L.   Samy M.   Santoro K.   Mark S.   Feldman D.  

Experimental and Molecular Pathology, Vol. 68, Iss. 1, 2000-02 ,pp. : 65-69

Elsevier

Access to resources Recommend Favorite

HER-2/neu Oncogene Amplification in Stage I And Stage III Ovarian Papillary Serous Carcinoma

By Afify A.M.   Werness B.A.   Mark H.F.L.  

Experimental and Molecular Pathology, Vol. 66, Iss. 2, 1999-06 ,pp. : 163-169

Elsevier

Access to resources Recommend Favorite

Confrontation of immunohistochemistry and fluorescent in situ hybridization for the assessment of HER-2/ neu (c- erb b-2) status in urothelial carcinoma

By de Pinieux Gonzague  

Virchows Archiv, Vol. 444, Iss. 5, 2004-05 ,pp. : 415-419

Springer Publishing Company

Access to resources Recommend Favorite

Fluorescence in Situ Hybridization Analysis of Biomarkers in Cancer

By Mark H.F.L.  

Experimental and Molecular Pathology, Vol. 67, Iss. 3, 1999-12 ,pp. : 131-134

Elsevier

Access to resources Recommend Favorite